Fusogenic membrane glycoproteins (FMGs) may enhance the cytotoxicity of conditionally replicative adenoviruses. However, expression at early stages of infection impairs virus replication. We have inserted the hyperfusogenic form of the gibbon ape leukemia virus (GALV) envelope glycoprotein as a new splice unit of the major late promoter (MLP) to generate a replication-competent adenovirus expressing this protein. At high multiplicity of infection (MOI), this virus replicated efficiently forming clumps of fused cells and showing a faster release. In contrast, at low MOI, infected cells formed syncytia where only one nucleus contained virus DNA, decreasing total virus production but increasing cytotoxicity.
Conditional replicative adenoviruses hold great promise for treating malignant solid tumors, because of their ability to replicate selectively within the tumor and kill neighboring cancer cells upon tumor cell lysis and secondary infection. 1 However, the oncolytic activity of these viruses needs to be improved substantially for effective cancer treatment. 2, 3 One possible method to enhance the efficacy of replicating adenovirus is arming the viruses with therapeutic transgenes. [4] [5] [6] [7] In this respect, it has been previously shown that expression of FMGs efficiently kills tumoral cells by inducing cell-cell fusion and massive syncytia formation. [8] [9] [10] [11] Various FMGs have been evaluated as a means to increase the potency of oncolytic viruses. 4, 6, [12] [13] [14] [15] [16] Expression of the HIV gp120 FMG by a replicative adenovirus enhanced viral release and facilitated dispersion of virus particles through a culture of tumor cells in vitro. 4 In addition, a more recent report demonstrated that coinjection of plasmid DNA encoding the hyperfusogenic form of the GALV envelope glycoprotein significantly enhanced the in vivo efficacy of the adenovirus therapy. 6 However, despite the interest on generating a replicative adenovirus expressing the GALV glycoprotein, previous attempts to produce adenoviral vectors encoding the GALV fusogenic protein have proven difficult, possibly due to premature cell fusion precluding virus replication. To overcome this problem the use of the modified human HSP70b promoter, a hyperthermia responsive promoter, 17 or the use of metalloproteinase-cleavable linkers to target the cytotoxicity of GALV-expressing adenoviral vectors against gliomas 18 has been reported. Here, we address this problem expressing GALV under the MLP. Further, GALV expression under the control of the MLP in a conditionally replicative adenovirus is desirable to prevent GALV expression in normal cells and uncontrolled induction of syncytia formation, because GALV receptor Pit-1 is ubiquitously expressed in human cells. In this paper, we describe a new replication-competent adenovirus that expresses the GALV glycoprotein in the late stage of virus replication. We have used this virus to evaluate how fusogenesis affects adenovirus production and cytotoxicity for future application in conditionally replicative adenoviruses.
Generation and characterization of AdwtRGD-GALV, a replicative adenovirus expressing the GALV FMG When dealing with replication-competent adenoviruses, it is desirable to express cytotoxic transgenes late in the viral life cycle to avoid early cell death. 5 Therefore, we cloned the coding sequence of the hyperfusogenic form of the GALV glycoprotein in the AdwtRGD genome under the control of the MLP. The adenovirus IIIa splicing acceptor was placed upstream of the GALV cDNA, and a polyA site downstream. This cassette was placed directly downstream of the fiber gene, as an L6 unit ( Figure 1a ). This strategy has been used previously 7, 19 and cloning strategies are available upon request. Transfection of the AdwtRGD-GALV genome into 293 cells led to massive syncytia formation ( Figure  1b) and virus generation. The new fusogenic adenovirus, AdwtRGD-GALV, and the control virus, AdwtRGD, 20 were efficiently propagated in 293 cells at high MOI. Whereas AdwtRGD induced a typical cytopathic effect characterized by cell rounding, swelling and loss of cellcell contact, cells infected at high MOI with AdwtRGD-GALV formed large spherical clumps of fused cells (Figure 1c ). The transducing units per ml of each cell extract were determined by a-hexon staining-based method, 21 and high-titer stocks were obtained for both viruses: 625 TU per cell for AdwtRGD-GALV and 486 TU per cell for AdwtRGD, indicating that GALV late expression was not impairing effective virus production. Because it was possible that the insertion of the GALV cassette downstream of the fiber gene reduced fiber expression, protein content of purified adenoviral vectors was confirmed by silver nitrate staining. Figure 1d shows that no differences in capsid composition were detected. To confirm the late expression of the GALV gene, A549 cells were infected at MOI of 10 with AdwtRGD-GALV. Total RNA from cell lysates was isolated at 12, 24, 48 and 72 h post infection, and was subjected to northern blot analysis with specific probes for E1a, Fiber and GALV RNAs. As shown in Figure 1e , E1a RNA was detected early in viral replication, whereas GALV RNA was expressed in the late phase, reproducing the pattern of fiber RNA.
Virus replication
To determine whether the insertion of the GALV transgene in the adenovirus genome and syncytium formation is detrimental to virus replication, we compared the one-step growth curves of AdwtRGD-GALV and AdwtRGD. A549 cells were infected at MOI of 10 with AdwtRGD and AdwtRGD-GALV, and the amount ) with 5% glycerol, and the particle titer was determined by OD. About 5 Â 10 10 vp of purified virions were boiled and separated by SDS-polyacrylamide gel electrophoresis and then stained with silver nitrate. (e) Time course of E1a, Fiber and GALV RNA expression from AdwtRGD-GALV. A549 cells were infected with AdwtRGD-GALV at MOI of 10 and total RNA was isolated at indicated time points. Extracted RNA were subjected to northern blot analysis with specific probes for E1a, Fiber and GALV. GALV, gibbon ape leukemia virus; MLP, major late promoter; MOI, multiplicity of infection; OD, optical density; PBS, phosphate-buffered saline.
Syncytia formation affects the yield and cytotoxicity S Guedan et al of virus in the supernatant and cell extracts was determined by a-hexon staining at various time points after infection. As shown in Figure 2Aa , total virus produced of both viruses was very similar, reaching approximately the same titer at the same time points. Interestingly, the amount of AdwtRGD-GALV released into the medium at 48 h post infection was almost 2-log higher than that of AdwtRGD, indicating a greater adenoviral release in presence of syncytia at high MOI (Figure 2Ab) . A representation of the ratio of virus released to total virus shows that at 48 h post infection almost 40% of the AdwtRGD-GALV produced is released to the supernatant in contrast to less than 0.5% of the AdwtRGD (Figure 2Ac) . At 72 h after infection, whereas more than 70% of AdwtRGD remained cell associated, all AdwtRGD-GALV was released. Next, we performed a multistep growth curve by infecting A549 at MOI of 0.1. Supernatants and cell extracts were harvested at 24-h intervals up to day 7 after infection. Large syncytia formed around infected cells and AdwtRGD-GALV viral titers were significantly lower than that of the AdwtRGD at all time points (Figures 2Ba and 2Bb) . Given a production impairment of AdwtRGD-GALV, one would expect a progressive divergence of titers with time. Initially, up to 72 and 96 h, there is such a clear divergence in the titers in supernatants and cell extracts, respectively. Later, the lack of divergence is not obvious and it may be explained by a saturating (plateau) level of AdwtRGD virus production. In summary, at high MOI, the fusogenic virus is produced as efficiently as AdwtRGD, but, at low MOI, the expression of the fusogenic protein decreases the amount of virus produced.
Viral replication in nuclei within syncytia
The low virus production in the presence of syncytia that arise at low MOI is contrasted with previous suggestions indicating that adenoviruses spread between the nucleus of a syncytium, thereby enhancing replication and increasing the amount of virus released. 4, 6 However, a more recent report indicated that adenovirus DNA does not normally undergo internuclear spreading between 12h 24h 48h 72h 96h 5 days 6 days 7 days 12h 24h 48h 72h 96h 5 days 6 days 7 days Syncytia formation affects the yield and cytotoxicity S Guedan et al nuclei within a syncytium, suggesting that efficient adenovirus replication cannot occur without extracellular particle spread. 22 As a result, most nuclei within a syncytium would die without producing new viral particles, limiting the total virus production. To test this, human melanoma cells, SKMel28, were infected at low MOI with AdwtRGD-GALV, and viral DNA was detected by fluorescent in situ hybridization 72 h after infection using AdwtRGD-GALV viral DNA stained by nick-translation as a probe. 23 Nuclei were detected by DAPI (4 0 ,6 0 -diamidino-2-phenylindole) staining. As shown in Figure 3 , the presence of viral DNA was only detected in one nucleus within a syncytium, in almost all the syncytia evaluated, indicating that fusogenic adenoviruses cannot efficiently spread between nuclei within a syncytium. This lack of viral DNA spreading among the nuclei within the syncytia would explain the lower virus yields when infecting at low MOI, and suggest that syncytia formation does not directly interfere with adenovirus replication.
Comparison of tumor cell killing in vitro
Despite the observed reduced virus yields, the cytotoxicity induced by a replication-competent adenovirus expressing a fusogenic protein, even at low MOI, could be enhanced compared with a non-fusogenic counterpart. To determine whether late GALV expression would enhance tumor cell killing, we infected SKMel28 cells with AdwtRGD and AdwtRGD-GALV at MOI of 5 or 0.5. Cells were harvested 72 h, 5 and 7 days after infection through trypsinization, and the number of viable cells was counted with a hemocytometer after Trypan blue staining. At MOI of 5, AdwtRGD-GALV killed more than 60% of tumor cells within 72 h, a time point where less than 45% of AdwtRGD-infected cells were dead. At MOI of 0.5, AdwtRGD-GALV reduced cell viability to less than 60% within 5 days, and at this same day most tumor cells infected with AdwtRGD were viable (Figure 4a ). Differences at day 7 after infection were still significant. The degree of tumor cell killing appeared to correlate with the extent of syncytia formation. To test this further, A549 and pancreatic tumor cells (NP9) were infected in a similar manner. Both cells were killed more effectively by AdwtRGD-GALV compared with AdwtRGD. Interestingly, at MOI of 0.7, AdwtRGD-GALV killed all A549 cells within 96 h, a time point where more than 50% of the AdwtRGD-infected cells were still viable. At MOI of 0.05, AdwtRGD-GALV reduced cell viability to less than 50% within 96 h while at the same time most of tumor cells infected with AdwtRGD were viable (Figure 4b ). These results indicate that the expression of GALV protein greatly enhances AdwtRGD cytotoxicity.
Collectively, our data demonstrate that expression of GALV under the MLP allows the generation of viable replication-competent adenoviruses. These fusogenic viruses are characterized by an enhanced cell killing despite detrimental effects on virus production from syncytia. These results warrant the construction of tumor-selective oncolytic adenoviruses using this strat- Syncytia formation affects the yield and cytotoxicity S Guedan et al
